SALT LAKE CITY, Sept. 06, 2017 -- Park City Group, Inc. (NASDAQ:PCYG), a cloud-based software company that uses big data management to help retailers and their suppliers ‘Sell more, Stock less and See everything’, today announced that the Company plans to release earnings results for its fiscal 2017 fourth quarter and year-end after the Market closes on Wednesday, September 13, 2017. Randall K. Fields, Chairman and CEO, will host a conference call at 4:15 P.M. Eastern that day to discuss the Company’s results. The conference call will also be webcast and will be available via the investor relations section of the Company’s website, www.parkcitygroup.com.
Participant Dial-In Numbers:
Date: Wednesday, September 13th
Time: 4:15 p.m. ET (1:15 P.M. PT)
TOLL-FREE 1-888-778-8913
TOLL/INTERNATIONAL 1-719-325-2348
Conference ID: 8591568
Replay Dial-In Numbers:
TOLL-FREE 1-844-512-2921
TOLL/INTERNATIONAL 1-412-317-6671
From: 9/13/17 @ 7:15 P.M. Eastern Time
To: 10/13/17 @ 11:59 P.M. Eastern Time
Replay Pin Number: 8591568
About Park City Group
Park City Group (PCYG) is a Software-as-a-Service (“SaaS”) provider that brings unique visibility to the consumer goods supply chain, delivering actionable information to ensure products are available when and where consumers demand them, helping retailers and suppliers to ‘Sell More, Stock Less, and See Everything’. Park City Group’s technology also assists all participants in the food and drug supply chains to comply with food and drug safety regulations through the Company’s ReposiTrak subsidiary. More information is available at www.parkcitygroup.com and www.repositrak.com.
Investor Relations Contact: Dave Mossberg Three Part Advisors, LLC 817-310-0051 Jeff Elliott Three Part Advisors, LLC 972-423-7070


FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Italy Fines Apple €98.6 Million Over App Store Dominance
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 



